(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire-FirstCall/--CellThe...llpresentatthe21stAnnualPiperJaffrayHealthCareConf...heNewYorkPalaceHotel. ,, CTIwillpresentonTuesda...r).AliveaudiowebcastofCTI,spresentationwillbeavail...ailableforreplayafterwards. , ,PiperJaffrayHealth...
(Date:11/23/2009)...HAMPAIGN, Ill. You can think of it as origami ve...sity of Illinois have developed a technique for fa...licon structures from thin films by coupling photo...apillary interactions. , The films, only a few mi...not possible with thicker pieces of the same mater...
(Date:11/23/2009)...raphene consists of a two-dimensional carbon layer...onal lattice, resembling a honeycomb. Carbon nanot...iles of graphene sheets form graphite. Graphene bo...emely tear-resistant, an excellent thermal conduct...rittleness and ductility. In addition, graphene is...
(Date:11/23/2009)..., MISSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-Y...cesproductdevelopmentcompanythatidentifiesandadvan...ctsatvariousstagesofdevelopment,todayreportedthatC...rialevaluatingCYT387,apotent,orally-administeredJA...nicinRochester,Minnesota.AproposaltomergeCytopiain...
Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2Polymer with honeycomb structure 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4...ring of outstanding convertible debentures of Vict...t , , QUEBEC, April 30 /PRNewswire-FirstCall/ - V...d Otto Bock HealthCare GmbH ("Otto Bock") announce...ership agreement to establish a joint venture to d...developed by Victhom,s Neurobionix division. , The...
... April 30 /PRNewswire-Asia-FirstCall/ -- China-Bio... Company"), a leading Chinese firm,specializing in... and,distribution of probiotics products ( http://... Company,s management will present at the upcoming...lations in New York on May 18,2009. , The date...
...RNewswire-FirstCall/ - Oncolytics Biotech Inc. (TS...2009 Annual and Special Meeting of the Shareholder.... (MT) at the Telus World of Science, 701-11 Stree... the meeting, Dr. Brad Thompson, President and CEO...veloping REOLYSIN(R) as a potential cancer therape...
Other Biology Technology:Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 2Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 3Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 4Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 5China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 2China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 3Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting 2...ue Arrays are intended for laboratory research use...al buffered formalin and embedded in paraffin. Ti... certified pathologists. Tissue cores were remove...new recipient paraffin block, in an array pattern,...
...ue Arrays are intended for laboratory research use...al buffered formalin and embedded in paraffin. Ti... certified pathologists. Tissue cores were remove...new recipient paraffin block, in an array pattern,...
...n rat tissue extracts (liver, kidney, spleen, and ... was also tested with microsomal fractions prepare...simple and reliable method for measuring NDPase ac...ction of the inorganic phosphate released from NDP...
CNS Side Effect Profile (CNS SEP) from Novascreen-a Caliper Life Sciences Company
Biology Products: